Research at Cellomere

At Cellomere, our work is driven by science, clinical experience, and a deep commitment to advancing regenerative medicine. With over a decade of clinical practice and innovation, Dr. Torbjörn Ogéus, DC, MSc, PgD, ScA, Co-Founder and Chief Scientific Officer of Cellomere, has contributed extensively to the field through peer-reviewed publications focused on stem cell biology, orthobiologics, and non-surgical regenerative strategies.

Dr. Ogéus’ research spans a wide range of applications, including the use of exosomes, platelet-rich fibrin (PRF), amniotic therapies, stromal vascular fraction (SVF), hydrogels, and novel bioactive combinations for conditions like osteoarthritis, meniscal injury, tendon damage, and post-traumatic joint degeneration.

He is also the lead author of a groundbreaking study on the isolation and activation of small pluripotent stem cells (SPSCs) from human peripheral blood — one of the first of its kind in Europe.

This page features his published clinical studies, reflecting the real-world outcomes of thousands of patients treated with biologically informed, minimally invasive regenerative approaches.